Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wein

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Computational Intelligence and Neuroscience|June 17, 2021
Brain Connectivity Studies on Structure-Function Relationships: A Short Survey with an Emphasis on Machine LearningSimon Wein, Gustavo Deco, Ana Maria Tomé, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 31, 2024
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolamSimon Wein, Marco Riebel, Philipp Seidel, et al.
Clinical Breast Cancer|December 14, 2017
Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 FusionYosef Landman, Maya Ilouze, Simon Wein, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 27, 2022
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment optionsRainer Rupprecht, Arpit Kumar Pradhan, Marco Kufner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2005
Palliative care for patients with cancer: what are the educational needs of community pharmacists?Safeera Y Hussainy, Jill Beattie, Roger L Nation, et al.
Trials|April 22, 2024
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept studyLisa-Marie Brunner, Marco Riebel, Simon Wein, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Computational Intelligence and Neuroscience|June 17, 2021
Brain Connectivity Studies on Structure-Function Relationships: A Short Survey with an Emphasis on Machine LearningSimon Wein, Gustavo Deco, Ana Maria Tomé, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 31, 2024
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolamSimon Wein, Marco Riebel, Philipp Seidel, et al.
Clinical Breast Cancer|December 14, 2017
Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 FusionYosef Landman, Maya Ilouze, Simon Wein, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 27, 2022
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment optionsRainer Rupprecht, Arpit Kumar Pradhan, Marco Kufner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2005
Palliative care for patients with cancer: what are the educational needs of community pharmacists?Safeera Y Hussainy, Jill Beattie, Roger L Nation, et al.
Trials|April 22, 2024
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept studyLisa-Marie Brunner, Marco Riebel, Simon Wein, et al.
Pageof 7